Chimpanzees suitable for biomedical research but held in facilities intended to provide long-term care and housing should be made available for research protocols, if needed, to maximize their utility and to contribute to the financial base required for their long-term support. In addition to emergency situations associated with new infectious disease epidemics, the older chimpanzees should be valuable for aging research.
To promote the use of government-owned chimpanzees by for-profit organizations, procedures to obtain access to the animals should be streamlined to minimize delays in initiating studies and to eliminate requirements for full disclosure of proprietary information.
Acute terminal studies involving chimpanzees are justified under some circumstances and, when possible, should be designed as collaborative efforts to yield the maximal amount of information with the potential to benefit more than one field of research. The ChiMP office, in consultation with colony directors and investigators, should identify candidate animals for such protocols.